本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

24.19
-0.3900-1.59%
盤後24.190.00000.00%19:59 EDT
成交量:90.08萬
成交額:2,167.12萬
市值:30.00億
市盈率:-190.68
高:24.62
開:24.56
低:23.68
收:24.58
52周最高:31.77
52周最低:12.42
股本:1.24億
流通股本:8,824.23萬
量比:0.91
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):-0.1269
每股收益(LYR):-0.1269
淨資產收益率:-9.30%
總資產收益率:-1.95%
市淨率:15.83
市盈率(LYR):-190.68

資料載入中...

2022/03/03

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/22

重要事件披露

8-K - Current report
2022/02/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/23

重要事件披露

8-K - Current report
2021/12/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/09

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

持股變動聲明

3/A [Amend] - Initial statement of beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/07

重要事件披露

8-K - Current report
2021/08/05

重要事件披露

8-K - Current report
2021/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/14

重要事件披露

8-K - Current report
2021/05/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report